Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: A phase II study

Journal of Neuro-Oncology

Volumn 32, Issue 2, 1997, Pages 155-160

  Ameri, A ^a   Poisson, M ^a   Chauveinc, L ^a   Chen, Q M ^a   Delattre, J Y ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Carboplatin; Etoposide; Recurrent malignant glioma

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRAIN TUMOR; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; HYPONATREMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; PHASE 2 CLINICAL TRIAL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SUPRATENTORIAL NEOPLASMS; TREATMENT OUTCOME;

EID: 0031047440     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005784425680     Document Type: Article

References (11)

1. Walker MD, Green SB, Byar DP et al.: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 303: 1323-1329, 1980
2. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WKA, Leavens SE, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields WS: Intracarotid infusion of cis diamminedichloroplatinium in the treatment of recurrent malignant brain tumors. Cancer 54: 794-799, 1984
3. Poisson M, Pereon Y, Chiras J, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA). J Neuro Oncol 10: 139-144, 1991
4. Yung WKA, Mechtler L, Gleason MJ: Intravenous carboplatin for recurrent malignant glioma: A phase II study. Clin Onc 9: 860-864, 1991
5. Aisner J, Lee EJ: Etoposide current and future status. Cancer 67: 215-219, 1991
6. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G: Primary glial tumor patients treated by combining cis-platin and etoposide. Neuro Onco 11: 165-170, 1991
7. Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langsten JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, Kun LE: Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other embryonal tumors of the central nervous system: A phase II study. Clin Onc 8: 330-336, 1990
8. Burger PC: Malignant astrocytic neoplasms: Classification, pathologic anatomy, and response to treatment. Semin in Oncology Vol 13 n1: 16-26, 1986
9. Rodriguez LA, Prados M, Silver P, Levin VA: Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer 64: 2420-2423, 1989
10. Jeremic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Ljubodrag D, Mijatovic L: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Onc 10: 1074-1077, 1992
11. Newton HB, Junck L, Bromberg J, Page MA, Greenberg HS: Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology 40: 1743-1746, 1990